LATEST ALERTS
A test case has demonstrated that the ECHR doesn’t consider access to cannabis to be a universal human right, and balancing a cannabis user’s human rights with public interest is best left to sovereign states
A cannabis regulation lawyer believes the UK Food Standards Agency (FSA) and the CBD sector have invested so much time, effort and money in the novel food process that it cannot be allowed to fail
The upcoming revision of the regulation of batteries in the EU may well have a profound effect the industry, with safety, sustainability and the environment all coming under the lawmakers’ microscope
This tracker outlines the ballot initiatives in the US that are likely to appear on ballot this November and will be updated periodically to keep the information up to date
The US Food and Drug Administration (FDA) recently appointed Norman Birenbaum to a top post as a senior public health adviser in the FDA’s Center for Regulatory Programs, signalling a seismic shift at the agency
In a first attempt to legalise cannabis through the federal parliament in Australia, the Greens party is in the process of drafting a law for legalisation that will be available for public consultation later this year
This report provides a detailed overview of the current regulatory framework in place in the Netherlands for hemp, cannabinoids such as CBD and cannabis
Legal hurdles impeding recreational cannabis legalisation in Mexico are expected to continue through 2024, industry members told CannIntelligence during the CannaMexico conference last month
The 8th November US midterm elections are just around the corner, and while the Republicans are favoured to win the majority, regardless of the outcome, things will change dramatically
The top European countries for importing and exporting cannabis for medical and scientific purposes covered in this report are slowly developing their frameworks with the primary goal of exporting and importing narcotics
Republicans are favoured over Democrats to take control of both chambers of US Congress in the midterm elections, but there are supporters and naysayers among both major parties when it comes to cannabis legalisation
Austria’s almost non-existent regime for the use of cannabinoids in medication has been described as “a Kafkaesque nightmare” with over-officious bureaucracy putting pointless hurdles in patients’ way
Stay up-to-date with key market trends and regulatory news and receive complimentary data on a regular basis.
"*" indicates required fields
Get 7 days of access to industry updates through our news analysis and regulatory alerts
"*" indicates required fields
Notifications
